Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures

Patent metadata

Field	Value
Publication number	US-10736656-B2
Application number	US-201916296688-A
Country	US
Kind code	B2
Filing date	Mar 8, 2019
Priority date	Oct 29, 2012
Publication date	Aug 11, 2020
Grant date	Aug 11, 2020

Abstract

An intravascular catheter for peri-vascular or peri-urethral tissue ablation includes multiple needles advanced through supported guide tubes which expand around a central axis to engage the interior surface of the wall of the renal artery or other vessel of a human body allowing the injection an ablative fluid for ablating tissue, or nerve fibers in the outer layer or deep to the outer layer of the vessel, or in prostatic tissue. A method can involve injection/infusion of the ablative fluid over an extended time period of at least 10 seconds or with two injections at two different penetration depths to reduce or eliminate patient pain during ablation.

First claim

What is claimed is:

1. A transvascular method of minimizing pain during the treatment of extravascular tissue, comprising: providing a catheter having an elongate flexible body, a proximal end, a distal end, a guide tube and a needle slidable within the guide tube; transvascularly positioning the distal end at a treatment site; advancing the guide tube against a vessel wall, without penetrating the vessel wall; deploying the needle through the guide tube into the vessel wall at a depth of more than 1 mm from an inside surface of the vessel wall; desensitizing pain nerves by injecting an anesthetic agent through the needle; and ablating sympathetic nerves by injecting an ablative agent through the needle.

2. The transvascular method of claim 1 , further comprising deploying at least three needles into the vessel wall.

3. The transvascular method of claim 2 , wherein deploying the at least three needles into the vessel wall comprises advancing at least three guide tubes into contact with the vessel wall and advancing the at least three needles out of the at least three guide tubes and into the vessel wall.

4. The transvascular method of claim 3 , further comprising centering the catheter by advancing the at least three guide tubes into contact with the vessel wall.

5. The transvascular method of claim 1 , wherein the anesthetic agent and the ablative agent are the same agent.

6. The transvascular method of claim 5 , wherein the anesthetic agent and the ablative agent are both ethanol.

7. The transvascular method of claim 6 , wherein a first volume of ethanol and a second volume of ethanol are injected in a continuous injection rate.

8. The transvascular method of claim 6 , wherein delivering a second volume of ethanol does not begin until at least 10 seconds following completion of delivering a first volume of ethanol.

9. The transvascular method of claim 6 , wherein a first volume of ethanol is injected at a first rate, and a second volume of ethanol is injected at a second, faster rate.

10. A transvascular method of minimizing pain during the treatment of extravascular tissue, comprising: providing a catheter having an elongate flexible body, a proximal end, a distal end, a guide tube and a needle disposed within a lumen of the guide tube; transvascularly positioning the distal end at a treatment site;
advancing the guide tube against a vessel wall; deploying the needle through the guide tube into the vessel wall at a depth of more than 1 mm from an inside surface of the vessel wall while maintaining the guide tube against the vessel wall; desensitizing pain nerves by injecting a first volume of ethanol through the needle; and
ablating sympathetic nerves by injecting a second volume of ethanol through the needle.

11. The transvascular method of claim 10 , further comprising deploying at least three needles into the vessel wall.

12. The transvascular method of claim 11 , wherein deploying the at least three needles into the vessel wall comprises advancing at least three guide tubes into contact with the vessel wall and advancing the at least three needles out of the at least three guide tubes and into the vessel wall.

13. The transvascular method of claim 12 , further comprising centering the catheter by advancing the at least three guide tubes into contact with the vessel wall.

14. The transvascular method of claim 10 , wherein the first volume of ethanol and the second volume of ethanol are injected in a continuous injection rate.

15. The transvascular method of claim 10 , wherein delivering the second volume of ethanol does not begin until at least 10 seconds following completion of delivering the first volume of ethanol.

16. The transvascular method of claim 10 , wherein the first volume of ethanol is injected at a first rate, and the second volume of ethanol is injected at a second, faster rate.

17. The transvascular method of claim 10 , further comprises injecting the first volume of ethanol at a rate of less than 2 ml per minute.

18. The transvascular method of claim 10 , further comprises injecting the first volume of ethanol at a rate of less than 1 ml per minute.

Assignees

• Ablative Solutions Inc
• Ablative Solutions

Inventors

• Fischell David R
• Fischell Tim A
• Ragland Robert Ryan
• Kent Darrin James
• Denison Andy Edward
• Johnson Eric Thomas
• Burke Jeff Alan
• Hayden Christopher Scott
• Fischell Robert E

Classifications

• A61B18/04

  by heating (by applying electromagnetic radiation A61B18/18) · CPC title

• A61B2018/1432

  curved · CPC title

• A61B18/06 Primary

  caused by chemical reaction {, e.g. moxaburners} · CPC title

• A61M25/0084

  being one or more injection needles · CPC title

• A61B17/3478

  Endoscopic needles, e.g. for infusion (biopsy needles A61B10/0233; catheters with injection needles A61M25/0067) · CPC title